The role of a group neuropsychological rehabilitation program in the cognitive and non-cognitive functioning of institutionalized elders

The role of a group neuropsychological rehabilitation program in the cognitive and non-cognitive functioning of institutionalized elders - Group neuropsychological rehabilitation program in institutionalized elders

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013567

Enrollment

144

Registered

2014-04-04

Start date

2012-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

institutionalized elders without cognitive impairment, but at risk of developing so (N/D-r) institutionalized elders with cognitive impairment no-dementia (CIND) institutionalized elders with dementia (DE)

Interventions

Seventy-two elders will be divided into three diagnostic classifications: 1) with N/D-r (n=24)

2) with CIND (n=24) and 3) with DE (n=24). Afterwards, the elders with N/D-r will be randomly assigned to the two rehabilitation groups (experimental) (n=12

6+6) and two waiting list groups (control) (n=12

6+6)

elders with CIND will also be randomly distributed into two rehabilitation groups (experimental) (n=12

the same with DE elders. Each elder subgroup (n=6) will take part in 10 sessions and will be evaluated cognitively (in the neuropsychological area) and non-cognitively (in the emotional/psychologica

verbal tasks), - Expressive Language (1, 3-5, 8-10 sessions including object naming, phonological and semantic fluency, and verbal comprehension tasks), - Constructive praxis (2, 5, 7, 9 sessions

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Institutionalized elders N/D-r, with CIND, and with DE, all with expressive-comprehensive communication capacities, able to see and hear well enough to participate.

Exclusion criteria

Exclusion criteria: Mental illness (e.g., major depression, psychosis), physical illness (e.g., CVA, brain tumor), or sensory illness (e.g., blindness, deafness) that may compromise their involvement in the tasks; use of medication that affects CNS (except cholinesterase inhibitor and/or SSRI).

Design outcomes

Primary

Measure	Time frame
Montreal Cognitive Assessment (MoCA) Frontal Assessment Battery (FAB) Geriatric Depression Scale (GDS) Geriatric Anxiety Scale (GAI) Positive Affect and Negative Affect Scale (PANAS) Satisfaction With Life Scale (SWLS) UCLA-Loneliness Scale (UCLA-LS)	—

Secondary

Measure	Time frame
Geriatric Functionality Scale (GFS)	—

Countries

Europe

Contacts

Public ContactHelena Espirito Santo

Instituto Superior Miguel Torga Psychology

helenum@gmail.com+351-966926933

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026